RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PALERMO F
Collezione AO Ordine Mauriziano

Items : 6

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study. in BMC cancer / BMC Cancer. 2024 May 6;24(1):563. doi: 10.1186/s12885-024-12328-0.

2024
AO Ordine Mauriziano

Niger M; Nichetti F; Fornaro L; Pircher C; Morano F; Palermo F; Rimassa L; Pressiani T; Berardi R; Gardini AC; Sperti E; Salvatore L; Melisi D; Bergamo F; Siena S; Mosconi S; Longarini R; Arcangeli G; Corallo S; Delliponti L; Tamberi S; Fea E; Brandi G; Rapposelli IG; Salati M; Baili P; Miceli R; Ljevar S; Cavallo I; et alii...

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study. in BMC cancer / BMC Cancer. 2024 Apr 8;24(1):436. doi: 10.1186/s12885-024-12225-6.

2024
AO Ordine Mauriziano

Lynch syndrome-associated endometrial cancer patient with a rare novel germline likely pathogenic variant of MSH2 gene: A case report. in Gynecologic oncology reports / Gynecol Oncol Rep. 2023 Jun 16;48:101220. doi: 10.1016/j.gore.2023.101220. eCollection 2023 Aug.

2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Valabrega G; Pasini B; Piva R; Turinetto M; Scotto G; Petracchini M; Palermo F; Siatis D; Vaira M; Tuninetti V; Zumstein L;

Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O(6)-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 May 10;40(14):1562-1573. doi: 10.1200/JCO.21.02583. Epub 2022 Mar 8.

2022
AO Ordine Mauriziano
AOU Città della Salute di Torino

Pietrantonio F; de Braud F; Milione M; Di Bartolomeo M; Di Maio M; Perrone F; Tamborini E; Brich S; Busico A; Conca E; Capone I; Marmorino F; Calegari MA; Cagnazzo C; Palazzo M; Zaniboni A; Ratti M; Bergamo F; Corti F; Niger M; Racca P; Prisciandaro M; Antonuzzo L; Pella N; Palermo F; Randon G; Murgioni S; Cremolini C; Lonardi S; et alii...

TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study. in Cancers / Cancers (Basel). 2021 Jun 7;13(11):2839. doi: 10.3390/cancers13112839.

2021
AO Ordine Mauriziano

Raimondi A; Palermo F; Prisciandaro M; Aglietta M; Antonuzzo L; Aprile G; Berardi R; Cardellino GG; De Manzoni G; De Vita F; Di Maio M; Fornaro L; Frassineti GL; Granetto C; Iachetta F; Lonardi S; Murialdo R; Ongaro E; Pucci F; Ratti M; Silvestris N; Smiroldo V; Spallanzani A; Strippoli A; Tamberi S; Tamburini E; Zaniboni A; Di Bartolomeo M; Cremolini C; et alii...

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2020 Mar 1;26(5):1017-1024. doi: 10.1158/1078-0432.CCR-19-3024. Epub 2019 Nov 18.

2020
AO Ordine Mauriziano

Milione M; Di Nicolantonio F; Tamborini E; Perrone F; Barault L; Macagno M; Martinetti A; Palermo F; Guarini V; Pagani F; Corallo S; Randon G; Gori S; Petrelli F; Farina G; Longarini R; Tomasello G; Sartore-Bianchi A; Murgioni S; Rimassa L; Mosconi S; Morano F; Raimondi A; Lonardi S; Antista M; Lobefaro R; Pietrantonio F; Di Maio M; Fucà G; et alii...